(EMAILWIRE.COM, March 23, 2017 ) According to a new market research report "Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021" published by MarketsandMarkets, the market is expected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%. http://www.marketsandmarkets.com/Market-Reports/blood-flow-measurement-devices-market-243081818.html

The global blood flow measurement devices market is segmented on the basis of product, application, and region.

Based on product, the blood flow measurement devices market is categorized into ultrasound and laser Doppler. In 2016, the ultrasound segment commanded the largest share of the global blood flow measurement device market. This growth can be attributed to the growing applications of ultrasound products, such as vascular diseases and dermatology, and their usability in invasive as well as non-invasive applications. The ultrasound market is further categorized into ultrasound Doppler and transit-time flow meters (TTFM). In 2016, the ultrasound Doppler segment commanded the largest share of the global ultrasound market. The large share and high growth rate of these devices can be attributed to their growing applications, ease of use, and increased preference for non-invasive devices.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=243081818

Based on application, the blood flow measurement devices market is segmented into non-invasive applications and invasive applications. Non-invasive applications are further categorized into cardiovascular disease, diabetes, tumor monitoring, gastroenterology, and others applications (dermatology and intracranial pressure monitoring). The cardiovascular disease segment commanded the largest share of the global blood flow measurement device market, by non-invasive applications, in 2016. The large share and high growth rate of this segment can be attributed to the increasing prevalence of cardiovascular disease, rising geriatric population, and increasing focus of key market players on this market. Similarly, invasive applications are further segmented into coronary arterial bypass graft (CABG), microvascular surgery, and others (organ transplants and reconstructive surgery). The CABG segment commanded the largest share of the global blood flow measurement devices market in 2016. The growth in this segment can be attributed to a large number of CABG surgeries performed worldwide.

The key players in the blood flow measurement devices market include Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), ADInstruments (Australia), Moor Instruments Ltd. (U.K.), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and SONOTEC Ultraschallsensorik Halle GmbH (Germany).

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com